Finder G6PD

FDA 510(k) K201049 · Baebies, Inc.

Substantially Equivalent

510(k) numberK201049

Submission

Device name
Finder G6PD
Applicant
Baebies, Inc.
Morrisville, NC, US
Received
April 21, 2020
Decision date
September 14, 2022
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
JBF – Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Screening
Device class
Class II (moderate risk)
Regulation
21 CFR 864.7360
Specialty
Hematology

Other 510(k)s with product code JBF

510(k)DeviceApplicantDecision
K161364BinaxNOW G6PD TestJBF · Special Alere Scarborough, Inc.06/17/2016SE
K080003Binaxnow G6PD TestJBF · Traditional Binax, Inc.10/23/2008SE
K024006G6PDH, GLUCOSE-6-PHOSHATE DehydrogenaseJBF · Traditional Pointe Scientific, Inc.,03/31/2003SE
K933934GLUCOSE-6-PHOSPHATE Dehydrogenase Deficiency Screening Test Kit No. 202-AJBF · Traditional Sigma Diagnostics, Inc.06/29/1995SE

More from Sigma Diagnostics, Inc.

510(k)DeviceDecision
K261837FINDER Flu A&B/SARS-CoV-2 TestQOF · Traditional 09/11/2026SE
K252269FINDER Flu A&B/SARS-CoV-2 TestQOF · Dual Track 03/30/2026SE

Questions and answers

When was Finder G6PD cleared by the FDA?

Finder G6PD (K201049) received a 510(k) decision of Substantially Equivalent on September 14, 2022, 876 days after the submission was received.

What is the product code of K201049?

The FDA product code is JBF – Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Screening, a Class II (moderate risk) device regulated under 21 CFR 864.7360.